| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 4.91e-09 | 20 | 146 | 6 | GO:0061665 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 7.42e-08 | 50 | 146 | 7 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.12e-07 | 53 | 146 | 7 | GO:0016859 | |
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD4 DOCK4 RGPD2 RANBP2 RGPD8 MYO9A STXBP5L RGPD1 IQGAP1 RGPD3 ARAP1 ARAP2 RGPD5 | 1.42e-07 | 279 | 146 | 13 | GO:0005096 |
| GeneOntologyMolecularFunction | SUMO transferase activity | 2.24e-07 | 36 | 146 | 6 | GO:0019789 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 DOCK4 RGPD2 CCZ1B RANBP2 RGPD8 MYO9A STXBP5L RGPD1 DOCK10 IQGAP1 CCZ1 RGPD3 ARAP1 ARAP2 RGPD5 | 9.84e-07 | 507 | 146 | 16 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 DOCK4 RGPD2 CCZ1B RANBP2 RGPD8 MYO9A STXBP5L RGPD1 DOCK10 IQGAP1 CCZ1 RGPD3 ARAP1 ARAP2 RGPD5 | 9.84e-07 | 507 | 146 | 16 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme activator activity | RGPD4 DOCK4 RGPD2 RANBP2 ERCC6 RGPD8 MYO9A STXBP5L RGPD1 IQGAP1 PTPA GUCA1A RGPD3 ARAP1 ARAP2 RGPD5 VEGFA | 6.34e-06 | 656 | 146 | 17 | GO:0008047 |
| GeneOntologyMolecularFunction | isomerase activity | 8.59e-05 | 192 | 146 | 8 | GO:0016853 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | RGPD4 RGPD2 RANBP2 NEDD4L RGPD8 DTL RGPD1 UBE2D2 UBE2D3 UBE2D4 RGPD3 SMURF2 CDC23 | 1.01e-04 | 512 | 146 | 13 | GO:0019787 |
| GeneOntologyMolecularFunction | small GTPase binding | RGPD4 DOCK4 RGPD2 RANBP2 RGPD8 RGPD1 DOCK10 GRIA1 IQGAP1 RGPD3 | 1.29e-04 | 321 | 146 | 10 | GO:0031267 |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | RGPD4 RGPD2 RANBP2 NEDD4L RGPD8 DTL RGPD1 UBE2D2 UBE2D3 UBE2D4 RGPD3 SMURF2 CDC23 | 1.48e-04 | 532 | 146 | 13 | GO:0016755 |
| GeneOntologyMolecularFunction | molecular function activator activity | RGPD4 DOCK4 RGPD2 RANBP2 ERCC6 CRLF1 RGPD8 MYO9A STXBP5L RGPD1 IQGAP1 PTPA GUCA1A EBI3 EPHA2 RGPD3 FGF2 ARAP1 ARAP2 RGPD5 VEGFA | 2.51e-04 | 1233 | 146 | 21 | GO:0140677 |
| GeneOntologyMolecularFunction | GTPase binding | RGPD4 DOCK4 RGPD2 RANBP2 RGPD8 RGPD1 DOCK10 GRIA1 IQGAP1 RGPD3 | 3.24e-04 | 360 | 146 | 10 | GO:0051020 |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 4.50e-04 | 49 | 146 | 4 | GO:0005547 | |
| GeneOntologyMolecularFunction | DNA translocase activity | 5.23e-04 | 5 | 146 | 2 | GO:0015616 | |
| GeneOntologyMolecularFunction | acyltransferase activity | RGPD4 RGPD2 RANBP2 NEDD4L RGPD8 DTL RGPD1 SIRT4 UBE2D2 UBE2D3 UBE2D4 RGPD3 CDYL SMURF2 CDC23 | 5.65e-04 | 775 | 146 | 15 | GO:0016746 |
| GeneOntologyMolecularFunction | enzyme regulator activity | RGPD4 DOCK4 RGPD2 CCZ1B RANBP2 ERCC6 RGPD8 MYO9A STXBP5L PPP1R3B RGPD1 DOCK10 RENBP IQGAP1 PTPA GUCA1A CCZ1 RGPD3 ARAP1 ARAP2 RGPD5 VEGFA | 6.37e-04 | 1418 | 146 | 22 | GO:0030234 |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | RGPD4 RGPD2 RANBP2 NEDD4L RGPD8 RGPD1 UBE2D2 UBE2D3 RGPD3 SMURF2 | 7.07e-04 | 398 | 146 | 10 | GO:0061659 |
| GeneOntologyMolecularFunction | amyloid-beta binding | 9.20e-04 | 102 | 146 | 5 | GO:0001540 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.76e-03 | 118 | 146 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ERCC6 MYO1A ATRX MYO9A DDX60 ACSS1 DNAH2 ABCB6 MYO1B CLU DYNC1H1 RAD54L | 1.87e-03 | 614 | 146 | 12 | GO:0140657 |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 8.61e-12 | 9 | 144 | 6 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 2.14e-11 | 10 | 144 | 6 | GO:1903301 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 5.01e-11 | 20 | 144 | 7 | GO:0006607 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.72e-10 | 13 | 144 | 6 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 2.99e-10 | 14 | 144 | 6 | GO:1903299 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 2.40e-07 | 38 | 144 | 6 | GO:0000413 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 2.04e-06 | 54 | 144 | 6 | GO:0018208 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | RGPD4 RGPD2 HNF1A RANBP2 ERCC6 CRLF1 RGPD8 LILRB2 RGPD1 IQGAP1 FNDC1 PTPA GUCA1A PTPRZ1 EPHA2 CD36 RGPD3 FGF2 CTNND1 VEGFA | 3.22e-06 | 879 | 144 | 20 | GO:0010562 |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | RGPD4 RGPD2 HNF1A RANBP2 ERCC6 CRLF1 RGPD8 LILRB2 RGPD1 IQGAP1 FNDC1 PTPA GUCA1A PTPRZ1 EPHA2 CD36 RGPD3 FGF2 CTNND1 VEGFA | 3.22e-06 | 879 | 144 | 20 | GO:0045937 |
| GeneOntologyBiologicalProcess | protein K11-linked ubiquitination | 5.63e-06 | 37 | 144 | 5 | GO:0070979 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 9.51e-06 | 195 | 144 | 9 | GO:0006606 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 1.03e-05 | 71 | 144 | 6 | GO:0006111 | |
| GeneOntologyBiologicalProcess | import into nucleus | 1.21e-05 | 201 | 144 | 9 | GO:0051170 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 1.29e-05 | 111 | 144 | 7 | GO:0006094 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 SRP19 SIRT4 CRY2 UBE2D3 CLU CD36 RGPD3 VPS53 RGPD5 | 1.55e-05 | 515 | 144 | 14 | GO:0072594 |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 1.63e-05 | 115 | 144 | 7 | GO:0019319 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 2.27e-05 | 121 | 144 | 7 | GO:0046364 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | RGPD4 RGPD2 HNF1A RANBP2 ERCC6 CRLF1 RGPD8 RGPD1 IQGAP1 FNDC1 PTPRZ1 EPHA2 CD36 RGPD3 FGF2 CTNND1 VEGFA | 3.23e-05 | 780 | 144 | 17 | GO:0042327 |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 3.98e-05 | 132 | 144 | 7 | GO:0043255 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | RGPD4 RGPD2 SEC16B RANBP2 RGPD8 ATRX RGPD1 BBS2 SRP19 SIRT4 CRY2 UBE2D3 BRD2 CLU CD36 RGPD3 IFT80 VPS53 RGPD5 VEGFA | 7.24e-05 | 1091 | 144 | 20 | GO:0033365 |
| GeneOntologyBiologicalProcess | protein K48-linked ubiquitination | 7.25e-05 | 100 | 144 | 6 | GO:0070936 | |
| GeneOntologyBiologicalProcess | protein K29-linked ubiquitination | 9.05e-05 | 13 | 144 | 3 | GO:0035519 | |
| GeneOntologyBiologicalProcess | protein K27-linked ubiquitination | 1.15e-04 | 14 | 144 | 3 | GO:0044314 | |
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 1.45e-04 | 3 | 144 | 2 | GO:0071691 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 1.71e-04 | 40 | 144 | 4 | GO:0097242 | |
| GeneOntologyBiologicalProcess | protein K6-linked ubiquitination | 2.11e-04 | 17 | 144 | 3 | GO:0085020 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-tyrosine autophosphorylation | 2.88e-04 | 4 | 144 | 2 | GO:1900086 | |
| GeneOntologyBiologicalProcess | regulation of amyloid-beta clearance | 3.48e-04 | 20 | 144 | 3 | GO:1900221 | |
| GeneOntologyBiologicalProcess | carbohydrate biosynthetic process | 3.51e-04 | 247 | 144 | 8 | GO:0016051 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 3.60e-04 | 134 | 144 | 6 | GO:0010906 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | RGPD4 RGPD2 HNF1A RANBP2 AKT3 ERCC6 CRLF1 RGPD8 RGPD1 SIRT4 IQGAP1 PTPRZ1 CD36 RGPD3 CTNND1 AGBL2 VEGFA | 4.72e-04 | 976 | 144 | 17 | GO:0018193 |
| GeneOntologyBiologicalProcess | regulation of peptidyl-tyrosine autophosphorylation | 4.77e-04 | 5 | 144 | 2 | GO:1900084 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.90e-12 | 8 | 146 | 6 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 2.15e-11 | 10 | 146 | 6 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 3.00e-10 | 14 | 146 | 6 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.81e-09 | 18 | 146 | 6 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 3.74e-09 | 20 | 146 | 6 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 5.21e-09 | 21 | 146 | 6 | GO:0106068 | |
| GeneOntologyCellularComponent | inclusion body | 3.23e-06 | 90 | 146 | 7 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear pore | 6.98e-06 | 101 | 146 | 7 | GO:0005643 | |
| GeneOntologyCellularComponent | transferase complex | RGPD4 RGPD2 RANBP2 RGPD8 FNTA DTL RGPD1 IFIT5 UBE2D2 UBE2D3 PHF20L1 UBE2D4 RGPD3 FBXO39 ANAPC5 SMURF2 CDC23 | 4.09e-04 | 963 | 146 | 17 | GO:1990234 |
| GeneOntologyCellularComponent | Mon1-Ccz1 complex | 4.78e-04 | 5 | 146 | 2 | GO:0035658 | |
| GeneOntologyCellularComponent | nuclear membrane | 7.92e-04 | 349 | 146 | 9 | GO:0031965 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 1.73e-09 | 16 | 112 | 6 | MP:0003701 | |
| MousePheno | abnormal morula morphology | 4.67e-08 | 26 | 112 | 6 | MP:0012058 | |
| MousePheno | increased hepatocellular carcinoma incidence | 8.24e-08 | 70 | 112 | 8 | MP:0003331 | |
| MousePheno | decreased tumor latency | 1.17e-07 | 30 | 112 | 6 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 1.45e-07 | 31 | 112 | 6 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 2.59e-07 | 34 | 112 | 6 | MP:0010307 | |
| MousePheno | abnormal blastocyst formation | 6.08e-07 | 39 | 112 | 6 | MP:0012128 | |
| MousePheno | abnormal mitosis | 8.47e-07 | 128 | 112 | 9 | MP:0004046 | |
| MousePheno | increased sarcoma incidence | 1.55e-06 | 102 | 112 | 8 | MP:0002032 | |
| MousePheno | increased hepatobiliary system tumor incidence | 2.94e-06 | 111 | 112 | 8 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 2.94e-06 | 111 | 112 | 8 | MP:0008019 | |
| MousePheno | aneuploidy | 8.97e-06 | 61 | 112 | 6 | MP:0004024 | |
| MousePheno | abnormal eye electrophysiology | 1.45e-05 | 228 | 112 | 10 | MP:0005551 | |
| MousePheno | increased lung carcinoma incidence | 3.72e-05 | 78 | 112 | 6 | MP:0008714 | |
| MousePheno | abnormal rod electrophysiology | 4.70e-05 | 119 | 112 | 7 | MP:0004021 | |
| MousePheno | abnormal chromosome number | 6.46e-05 | 86 | 112 | 6 | MP:0004023 | |
| MousePheno | abnormal chromosome morphology | 6.77e-05 | 126 | 112 | 7 | MP:0003702 | |
| MousePheno | increased incidence of induced tumors | 7.46e-05 | 173 | 112 | 8 | MP:0002021 | |
| MousePheno | abnormal cell nucleus morphology | 1.15e-04 | 184 | 112 | 8 | MP:0003111 | |
| MousePheno | increased malignant tumor incidence | 1.20e-04 | 237 | 112 | 9 | MP:0002018 | |
| MousePheno | increased incidence of tumors by chemical induction | 1.37e-04 | 141 | 112 | 7 | MP:0004499 | |
| MousePheno | enlarged epididymis | 1.41e-04 | 99 | 112 | 6 | MP:0004931 | |
| MousePheno | increased carcinoma incidence | 1.84e-04 | 197 | 112 | 8 | MP:0002038 | |
| MousePheno | abnormal spinal cord ventral horn morphology | 2.12e-04 | 15 | 112 | 3 | MP:0005112 | |
| MousePheno | increased respiratory system tumor incidence | 2.17e-04 | 107 | 112 | 6 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 2.17e-04 | 107 | 112 | 6 | MP:0008014 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 2.17e-04 | 107 | 112 | 6 | MP:0003694 | |
| MousePheno | abnormal blastocyst hatching | 2.91e-04 | 113 | 112 | 6 | MP:0003693 | |
| MousePheno | abnormal incidence of induced tumors | 3.09e-04 | 269 | 112 | 9 | MP:0013151 | |
| MousePheno | abnormal eye physiology | RGPD4 RGPD2 RANBP2 ERCC6 RGPD8 LAMA1 RGPD1 ELP1 BBS2 TTPA GUCA1A CD36 RGPD3 VEGFA | 3.39e-04 | 606 | 112 | 14 | MP:0005253 |
| MousePheno | abnormal preimplantation embryo morphology | 4.48e-04 | 283 | 112 | 9 | MP:0014137 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 4.83e-04 | 286 | 112 | 9 | MP:0008873 | |
| MousePheno | retroesophageal right subclavian artery | 6.90e-04 | 22 | 112 | 3 | MP:0004160 | |
| Domain | Ran_BP1 | 1.07e-12 | 12 | 144 | 7 | PF00638 | |
| Domain | RANBD1 | 1.07e-12 | 12 | 144 | 7 | PS50196 | |
| Domain | RanBD | 2.31e-12 | 13 | 144 | 7 | SM00160 | |
| Domain | Ran_bind_dom | 2.31e-12 | 13 | 144 | 7 | IPR000156 | |
| Domain | Grip | 8.47e-11 | 11 | 144 | 6 | SM00755 | |
| Domain | GRIP | 8.47e-11 | 11 | 144 | 6 | PF01465 | |
| Domain | GRIP_dom | 1.68e-10 | 12 | 144 | 6 | IPR000237 | |
| Domain | GRIP | 1.68e-10 | 12 | 144 | 6 | PS50913 | |
| Domain | Rab_bind | 5.27e-10 | 7 | 144 | 5 | PF16704 | |
| Domain | GCC2_Rab_bind | 5.27e-10 | 7 | 144 | 5 | IPR032023 | |
| Domain | - | 6.21e-09 | 10 | 144 | 5 | 1.10.220.60 | |
| Domain | TPR_REGION | RGPD4 RGPD2 RANBP2 RGPD8 DNAH2 RGPD1 IFIT5 RGPD3 ANAPC5 CDC23 RGPD5 | 6.22e-08 | 165 | 144 | 11 | PS50293 |
| Domain | TPR | RGPD4 RGPD2 RANBP2 RGPD8 DNAH2 RGPD1 IFIT5 RGPD3 ANAPC5 CDC23 RGPD5 | 6.22e-08 | 165 | 144 | 11 | PS50005 |
| Domain | TPR-contain_dom | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 IFIT5 RGPD3 ANAPC5 CDC23 RGPD5 | 2.53e-07 | 150 | 144 | 10 | IPR013026 |
| Domain | TPR | 7.00e-07 | 129 | 144 | 9 | SM00028 | |
| Domain | TPR_repeat | 9.06e-07 | 133 | 144 | 9 | IPR019734 | |
| Domain | PH_dom-like | RGPD4 RGPD2 RANBP2 AKT3 RGPD8 RGPD1 DOCK10 MYO1B RGPD3 SNTG2 PLEKHH2 ARAP1 ARAP2 FERMT3 RGPD5 | 1.07e-06 | 426 | 144 | 15 | IPR011993 |
| Domain | TPR-like_helical_dom | RGPD4 UTP6 RGPD2 RANBP2 RGPD8 RGPD1 IFIT5 RGPD3 ANAPC5 CDC23 RGPD5 | 1.96e-06 | 233 | 144 | 11 | IPR011990 |
| Domain | - | RGPD4 UTP6 RGPD2 RANBP2 RGPD8 RGPD1 IFIT5 RGPD3 ANAPC5 CDC23 | 4.76e-06 | 207 | 144 | 10 | 1.25.40.10 |
| Domain | fn3 | 3.74e-05 | 162 | 144 | 8 | PF00041 | |
| Domain | IQ | 3.82e-05 | 81 | 144 | 6 | SM00015 | |
| Domain | - | RGPD4 RGPD2 RANBP2 AKT3 RGPD8 RGPD1 DOCK10 RGPD3 PLEKHH2 ARAP1 ARAP2 FERMT3 | 5.18e-05 | 391 | 144 | 12 | 2.30.29.30 |
| Domain | DUF1712 | 5.90e-05 | 2 | 144 | 2 | PF08217 | |
| Domain | DUF1712_fun | 5.90e-05 | 2 | 144 | 2 | IPR013176 | |
| Domain | TPR_1 | 6.92e-05 | 90 | 144 | 6 | IPR001440 | |
| Domain | TPR_1 | 6.92e-05 | 90 | 144 | 6 | PF00515 | |
| Domain | IQ_motif_EF-hand-BS | 6.92e-05 | 90 | 144 | 6 | IPR000048 | |
| Domain | IQ | 8.31e-05 | 93 | 144 | 6 | PS50096 | |
| Domain | FN3 | 9.52e-05 | 185 | 144 | 8 | SM00060 | |
| Domain | FN3 | 1.58e-04 | 199 | 144 | 8 | PS50853 | |
| Domain | IQ | 2.20e-04 | 71 | 144 | 5 | PF00612 | |
| Domain | FN3_dom | 2.20e-04 | 209 | 144 | 8 | IPR003961 | |
| Domain | Nebulin | 3.51e-04 | 4 | 144 | 2 | PF00880 | |
| Domain | NEBULIN | 3.51e-04 | 4 | 144 | 2 | PS51216 | |
| Domain | NEBU | 3.51e-04 | 4 | 144 | 2 | SM00227 | |
| Domain | Nebulin | 3.51e-04 | 4 | 144 | 2 | IPR013998 | |
| Domain | Nebulin_repeat | 3.51e-04 | 4 | 144 | 2 | IPR000900 | |
| Domain | UBQ-conjugating_AS | 9.12e-04 | 25 | 144 | 3 | IPR023313 | |
| Domain | Myosin_TH1 | 1.21e-03 | 7 | 144 | 2 | PF06017 | |
| Domain | Myosin_TH1 | 1.21e-03 | 7 | 144 | 2 | IPR010926 | |
| Domain | Plakophilin/d_Catenin | 1.21e-03 | 7 | 144 | 2 | IPR028435 | |
| Domain | TH1 | 1.21e-03 | 7 | 144 | 2 | PS51757 | |
| Domain | DHC_N1 | 1.60e-03 | 8 | 144 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.60e-03 | 8 | 144 | 2 | IPR013594 | |
| Domain | SNF2_N | 1.89e-03 | 32 | 144 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.89e-03 | 32 | 144 | 3 | PF00176 | |
| Domain | RA | 2.66e-03 | 36 | 144 | 3 | PF00788 | |
| Domain | RA | 2.88e-03 | 37 | 144 | 3 | PS50200 | |
| Domain | DHR-1_domain | 3.10e-03 | 11 | 144 | 2 | IPR027007 | |
| Domain | DHR_2 | 3.10e-03 | 11 | 144 | 2 | PS51651 | |
| Domain | DHR_1 | 3.10e-03 | 11 | 144 | 2 | PS51650 | |
| Domain | DHR-2 | 3.10e-03 | 11 | 144 | 2 | PF06920 | |
| Domain | DOCK | 3.10e-03 | 11 | 144 | 2 | IPR026791 | |
| Domain | DOCK_C | 3.10e-03 | 11 | 144 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 3.10e-03 | 11 | 144 | 2 | PF14429 | |
| Domain | DHR-2 | 3.10e-03 | 11 | 144 | 2 | IPR027357 | |
| Domain | Myosin_head_motor_dom | 3.11e-03 | 38 | 144 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 3.11e-03 | 38 | 144 | 3 | PS51456 | |
| Domain | Myosin_head | 3.11e-03 | 38 | 144 | 3 | PF00063 | |
| Domain | MYSc | 3.11e-03 | 38 | 144 | 3 | SM00242 | |
| Domain | UQ_con | 3.35e-03 | 39 | 144 | 3 | PF00179 | |
| Domain | RA_dom | 3.60e-03 | 40 | 144 | 3 | IPR000159 | |
| Domain | UBIQUITIN_CONJUGAT_1 | 3.60e-03 | 40 | 144 | 3 | PS00183 | |
| Domain | UBIQUITIN_CONJUGAT_2 | 3.86e-03 | 41 | 144 | 3 | PS50127 | |
| Domain | UBQ-conjugat_E2 | 3.86e-03 | 41 | 144 | 3 | IPR000608 | |
| Domain | Rho_GTPase_activation_prot | 4.79e-03 | 88 | 144 | 4 | IPR008936 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.06e-03 | 14 | 144 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.06e-03 | 14 | 144 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.06e-03 | 14 | 144 | 2 | IPR013602 | |
| Domain | DHC_N2 | 5.06e-03 | 14 | 144 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 5.06e-03 | 14 | 144 | 2 | IPR011704 | |
| Domain | MT | 5.06e-03 | 14 | 144 | 2 | PF12777 | |
| Domain | AAA_8 | 5.06e-03 | 14 | 144 | 2 | PF12780 | |
| Domain | CNH | 5.06e-03 | 14 | 144 | 2 | SM00036 | |
| Domain | AAA_5 | 5.06e-03 | 14 | 144 | 2 | PF07728 | |
| Domain | WW | 5.68e-03 | 47 | 144 | 3 | PF00397 | |
| Domain | DHC_fam | 5.80e-03 | 15 | 144 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 5.80e-03 | 15 | 144 | 2 | PF03028 | |
| Domain | CNH | 5.80e-03 | 15 | 144 | 2 | PF00780 | |
| Domain | Dynein_heavy_dom | 5.80e-03 | 15 | 144 | 2 | IPR004273 | |
| Domain | CNH | 5.80e-03 | 15 | 144 | 2 | PS50219 | |
| Domain | CNH_dom | 5.80e-03 | 15 | 144 | 2 | IPR001180 | |
| Domain | PH | 5.85e-03 | 278 | 144 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 5.96e-03 | 279 | 144 | 7 | PS50003 | |
| Domain | WW | 6.02e-03 | 48 | 144 | 3 | SM00456 | |
| Domain | PH_domain | 6.08e-03 | 280 | 144 | 7 | IPR001849 | |
| Domain | - | 7.13e-03 | 51 | 144 | 3 | 3.10.110.10 | |
| Domain | WW_DOMAIN_1 | 7.13e-03 | 51 | 144 | 3 | PS01159 | |
| Domain | WW_DOMAIN_2 | 7.13e-03 | 51 | 144 | 3 | PS50020 | |
| Domain | WW_dom | 7.53e-03 | 52 | 144 | 3 | IPR001202 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 3.98e-09 | 18 | 113 | 6 | MM1549 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 3.97e-07 | 117 | 113 | 9 | MM15387 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 7.14e-07 | 40 | 113 | 6 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 8.30e-07 | 41 | 113 | 6 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 9.63e-07 | 42 | 113 | 6 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.11e-06 | 43 | 113 | 6 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.91e-06 | 47 | 113 | 6 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 2.45e-06 | 49 | 113 | 6 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.77e-06 | 50 | 113 | 6 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 3.12e-06 | 51 | 113 | 6 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 4.89e-06 | 55 | 113 | 6 | MM14917 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 5.62e-06 | 86 | 113 | 7 | MM15413 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 6.69e-06 | 58 | 113 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 6.69e-06 | 58 | 113 | 6 | MM14736 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | RGPD4 RGPD2 SIN3B RANBP2 AKT3 RGPD8 MINK1 RGPD1 CREBRF UBE2D2 UBE2D3 RGPD3 ANAPC5 DYNC1H1 CDC23 | 1.19e-05 | 505 | 113 | 15 | MM15548 |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.30e-05 | 65 | 113 | 6 | MM15147 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 1.53e-05 | 100 | 113 | 7 | MM14561 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 2.46e-05 | 193 | 113 | 9 | MM14890 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.55e-05 | 73 | 113 | 6 | MM14948 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 4.95e-05 | 82 | 113 | 6 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 5.68e-05 | 84 | 113 | 6 | MM14929 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 7.89e-05 | 129 | 113 | 7 | MM14894 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 9.45e-05 | 92 | 113 | 6 | MM14951 | |
| Pathway | KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS | 1.05e-04 | 135 | 113 | 7 | M15247 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 1.10e-04 | 234 | 113 | 9 | MM14898 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.38e-04 | 141 | 113 | 7 | MM15266 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RGPD4 DOCK4 RGPD2 RANBP2 RGPD8 MYO9A PKP4 RGPD1 DOCK10 IQGAP1 EPHA2 RGPD3 DYNC1H1 ARAP1 ARAP2 | 2.06e-04 | 649 | 113 | 15 | MM15690 |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 2.19e-04 | 202 | 113 | 8 | MM15362 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 3.07e-04 | 114 | 113 | 6 | MM15361 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 3.28e-04 | 271 | 113 | 9 | MM15388 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 3.85e-04 | 277 | 113 | 9 | MM15414 | |
| Pathway | WP_BURN_WOUND_HEALING | 6.00e-04 | 21 | 113 | 3 | MM15978 | |
| Pathway | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | 8.98e-04 | 24 | 113 | 3 | MM14877 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 1.08e-03 | 257 | 113 | 8 | MM14755 | |
| Pathway | REACTOME_M_PHASE | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 RGPD3 ANAPC5 PLK4 DYNC1H1 CDC23 | 1.09e-03 | 387 | 113 | 10 | MM15364 |
| Pubmed | 3.44e-14 | 7 | 146 | 6 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 3.44e-14 | 7 | 146 | 6 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 3.44e-14 | 7 | 146 | 6 | 11353387 | |
| Pubmed | 3.44e-14 | 7 | 146 | 6 | 30944974 | ||
| Pubmed | 3.44e-14 | 7 | 146 | 6 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 3.44e-14 | 7 | 146 | 6 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 3.44e-14 | 7 | 146 | 6 | 17372272 | |
| Pubmed | 3.44e-14 | 7 | 146 | 6 | 38657106 | ||
| Pubmed | 3.44e-14 | 7 | 146 | 6 | 21205196 | ||
| Pubmed | 3.44e-14 | 7 | 146 | 6 | 18949001 | ||
| Pubmed | 3.44e-14 | 7 | 146 | 6 | 25187515 | ||
| Pubmed | 3.44e-14 | 7 | 146 | 6 | 8603673 | ||
| Pubmed | 3.44e-14 | 7 | 146 | 6 | 26632511 | ||
| Pubmed | 3.44e-14 | 7 | 146 | 6 | 24403063 | ||
| Pubmed | 3.44e-14 | 7 | 146 | 6 | 23818861 | ||
| Pubmed | 3.44e-14 | 7 | 146 | 6 | 23536549 | ||
| Pubmed | 3.44e-14 | 7 | 146 | 6 | 12191015 | ||
| Pubmed | 3.44e-14 | 7 | 146 | 6 | 22821000 | ||
| Pubmed | 3.44e-14 | 7 | 146 | 6 | 20682751 | ||
| Pubmed | 1.24e-13 | 15 | 146 | 7 | 14697343 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 1.37e-13 | 8 | 146 | 6 | 21670213 | |
| Pubmed | 1.37e-13 | 8 | 146 | 6 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.37e-13 | 8 | 146 | 6 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 1.37e-13 | 8 | 146 | 6 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 1.37e-13 | 8 | 146 | 6 | 28745977 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 4.10e-13 | 9 | 146 | 6 | 18394993 | |
| Pubmed | 4.10e-13 | 9 | 146 | 6 | 28100513 | ||
| Pubmed | 4.10e-13 | 9 | 146 | 6 | 17887960 | ||
| Pubmed | 4.10e-13 | 9 | 146 | 6 | 11553612 | ||
| Pubmed | 4.10e-13 | 9 | 146 | 6 | 10601307 | ||
| Pubmed | 4.10e-13 | 9 | 146 | 6 | 9733766 | ||
| Pubmed | 4.10e-13 | 9 | 146 | 6 | 28877029 | ||
| Pubmed | 1.02e-12 | 10 | 146 | 6 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 1.02e-12 | 10 | 146 | 6 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 1.02e-12 | 10 | 146 | 6 | 8857542 | |
| Pubmed | 1.02e-12 | 10 | 146 | 6 | 21859863 | ||
| Pubmed | 2.24e-12 | 11 | 146 | 6 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 2.24e-12 | 11 | 146 | 6 | 35771867 | |
| Pubmed | 2.24e-12 | 11 | 146 | 6 | 34110283 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 8.26e-12 | 13 | 146 | 6 | 31427429 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 ELP1 PRPF8 RGPD3 EIF3D ANAPC5 CDC23 | 5.46e-11 | 153 | 146 | 11 | 26365490 |
| Pubmed | RGPD4 RGPD2 RANBP2 RGPD8 MYO1A ATRX DTL DNAH2 RGPD1 IFIT5 GRIA1 MYO1B NEB PRPF8 IQGAP1 CREBRF BRD2 WDR75 PHF20L1 RGPD3 SUPT16H ALDH1B1 SMURF2 DOP1A PHTF1 RGPD5 | 3.33e-10 | 1442 | 146 | 26 | 35575683 | |
| Pubmed | 3.48e-10 | 22 | 146 | 6 | 27717094 | ||
| Pubmed | RGPD4 RGPD2 RANBP2 RGPD8 MYO9A PKP4 RPS10 RGPD1 NEB PRPF8 IQGAP1 UBE2D2 UBE2D3 UBE2D4 CLU RGPD3 EIF3D CTNND1 DYNC1H1 RGPD5 | 4.63e-10 | 844 | 146 | 20 | 25963833 | |
| Pubmed | RGPD4 CNTN4 RGPD2 SIN3B RANBP2 NEDD4L RGPD8 PKP4 MINK1 RGPD1 GRIA1 IQGAP1 CLU RGPD3 SUPT16H ZSCAN18 LRP1 CTNND1 DYNC1H1 FERMT3 | 4.39e-09 | 963 | 146 | 20 | 28671696 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 1.22e-08 | 38 | 146 | 6 | 12791264 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 5.53e-08 | 231 | 146 | 10 | 16452087 | |
| Pubmed | 8.10e-08 | 86 | 146 | 7 | 37253089 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 RGPD2 RANBP2 RGPD8 DTL RGPD1 PRPF8 CWC22 IQGAP1 CRY2 PHF20L1 CLU RGPD3 EIF3D ANAPC5 PLK4 DYNC1H1 ARAP1 CDC23 RGPD5 | 8.75e-08 | 1155 | 146 | 20 | 20360068 |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 1.12e-07 | 135 | 146 | 8 | 31077711 | |
| Pubmed | The UbL protein UBTD1 stably interacts with the UBE2D family of E2 ubiquitin conjugating enzymes. | 1.44e-07 | 12 | 146 | 4 | 24211586 | |
| Pubmed | 2.14e-07 | 99 | 146 | 7 | 27746211 | ||
| Pubmed | 2.89e-07 | 4 | 146 | 3 | 12496364 | ||
| Pubmed | 2.89e-07 | 4 | 146 | 3 | 9480752 | ||
| Pubmed | Biological insights from 108 schizophrenia-associated genetic loci. | 6.77e-07 | 303 | 146 | 10 | 25056061 | |
| Pubmed | The RING-H2 protein RNF11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase. | 7.20e-07 | 5 | 146 | 3 | 14562029 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | RGPD4 RGPD2 RANBP2 RGPD8 RPS10 RGPD1 MYO1B PRPF8 IQGAP1 BRD2 RGPD3 SUPT16H EIF3D DYNC1H1 | 9.05e-07 | 665 | 146 | 14 | 30457570 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CCZ1B RANBP2 ATRX ELP1 SRP19 PRPF8 IQGAP1 BRD2 CCZ1 CTNND1 DYNC1H1 ARAP1 CDC23 | 1.18e-06 | 582 | 146 | 13 | 20467437 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD4 RGPD2 CCZ1B RANBP2 RGPD8 DTL RPS10 RGPD1 ELP1 MYO1B PRPF8 WDR75 CCZ1 RGPD3 ALDH1B1 CTNND1 DYNC1H1 CDC23 RGPD5 | 1.45e-06 | 1257 | 146 | 19 | 37317656 |
| Pubmed | 2.51e-06 | 7 | 146 | 3 | 23604117 | ||
| Pubmed | 2.51e-06 | 7 | 146 | 3 | 24831002 | ||
| Pubmed | The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor. | 2.51e-06 | 7 | 146 | 3 | 21685362 | |
| Pubmed | 2.51e-06 | 7 | 146 | 3 | 20051513 | ||
| Pubmed | 2.51e-06 | 7 | 146 | 3 | 22613722 | ||
| Pubmed | 2.51e-06 | 7 | 146 | 3 | 30884854 | ||
| Pubmed | Structure of a ubiquitin-loaded HECT ligase reveals the molecular basis for catalytic priming. | 2.51e-06 | 7 | 146 | 3 | 23644597 | |
| Pubmed | 2.51e-06 | 7 | 146 | 3 | 33282879 | ||
| Pubmed | 2.97e-06 | 24 | 146 | 4 | 33705438 | ||
| Pubmed | Structure and catalytic activation of the TRIM23 RING E3 ubiquitin ligase. | 4.00e-06 | 8 | 146 | 3 | 28681414 | |
| Pubmed | 4.00e-06 | 8 | 146 | 3 | 28972136 | ||
| Pubmed | Ube2W conjugates ubiquitin to α-amino groups of protein N-termini. | 4.00e-06 | 8 | 146 | 3 | 23560854 | |
| Pubmed | Ubiquitination of alpha-synuclein filaments by Nedd4 ligases. | 4.00e-06 | 8 | 146 | 3 | 30021006 | |
| Pubmed | 4.00e-06 | 8 | 146 | 3 | 25207814 | ||
| Pubmed | Hypermutation of immunoglobulin genes in memory B cells of DNA repair-deficient mice. | 4.00e-06 | 8 | 146 | 3 | 9607915 | |
| Pubmed | 4.00e-06 | 8 | 146 | 3 | 20595234 | ||
| Pubmed | 4.00e-06 | 8 | 146 | 3 | 29323787 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 SLU7 IQGAP1 WDR75 RGPD3 DYNC1H1 | 4.04e-06 | 370 | 146 | 10 | 22922362 |
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 4.15e-06 | 26 | 146 | 4 | 26949039 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UTP6 RANBP2 ERCC6 MYO9A PKP4 RPS10 DOCK10 ELP1 SLU7 MYO1B PRPF8 IQGAP1 MEMO1 WDR75 SUPT16H EIF3D ALDH1B1 CTNND1 DYNC1H1 | 4.22e-06 | 1353 | 146 | 19 | 29467282 |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 5.48e-06 | 226 | 146 | 8 | 37839992 | |
| Pubmed | 7.07e-06 | 234 | 146 | 8 | 36243803 | ||
| Pubmed | 8.51e-06 | 10 | 146 | 3 | 37345264 | ||
| Pubmed | 8.51e-06 | 10 | 146 | 3 | 31087003 | ||
| Pubmed | 8.51e-06 | 10 | 146 | 3 | 28757353 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | UTP6 RANBP2 RPS10 ELP1 SRP19 PRPF8 IQGAP1 MEMO1 RGPD3 SUPT16H EIF3D DYNC1H1 CDC23 | 9.27e-06 | 704 | 146 | 13 | 29955894 |
| Pubmed | Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. | 1.03e-05 | 68 | 146 | 5 | 22001757 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.36e-05 | 256 | 146 | 8 | 33397691 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 25735814 | ||
| Pubmed | Pro-neoangiogenic cytokines (VEGF and bFGF) and anemia in solid tumor patients. | 1.75e-05 | 2 | 146 | 2 | 15756443 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 26912277 | ||
| Pubmed | [Expression and clinical significance of serum VEGF and bFGF in children with acute leukemia]. | 1.75e-05 | 2 | 146 | 2 | 22125837 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 28212375 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 27130666 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 20646480 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 21143350 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 10942527 | ||
| Pubmed | Serum levels of VEGF and bFGF in hypoxic patients with exacerbated COPD. | 1.75e-05 | 2 | 146 | 2 | 20504760 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 26712576 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 30475537 | ||
| Pubmed | Development and characterisation of SMURF2-targeting modifiers. | 1.75e-05 | 2 | 146 | 2 | 33430646 | |
| Interaction | RGPD4 interactions | 1.34e-10 | 22 | 145 | 7 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 6.79e-10 | 27 | 145 | 7 | int:RGPD2 | |
| Interaction | RGPD3 interactions | 4.27e-08 | 47 | 145 | 7 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 5.76e-08 | 49 | 145 | 7 | int:RGPD1 | |
| Interaction | MCM2 interactions | RGPD4 RGPD2 RANBP2 RGPD8 ATRX MYO9A TNIP2 PKP4 RPS10 RGPD1 ELP1 NEB IQGAP1 UBE2D2 UBE2D3 UBE2D4 CLU EPHA2 RGPD3 SUPT16H EIF3D CTNND1 DYNC1H1 RGPD5 | 7.90e-07 | 1081 | 145 | 24 | int:MCM2 |
| Interaction | RGPD8 interactions | 1.04e-06 | 74 | 145 | 7 | int:RGPD8 | |
| Interaction | RCC1 interactions | 2.00e-06 | 201 | 145 | 10 | int:RCC1 | |
| Interaction | RGPD5 interactions | 6.03e-06 | 96 | 145 | 7 | int:RGPD5 | |
| Interaction | NPIPB6 interactions | 7.27e-06 | 18 | 145 | 4 | int:NPIPB6 | |
| Interaction | RANBP2 interactions | RGPD4 RGPD2 RANBP2 RGPD8 TNIP2 RGPD1 PRPF8 CRY2 RGPD3 SUPT16H USP4 RGPD5 | 1.21e-05 | 361 | 145 | 12 | int:RANBP2 |
| Interaction | USP7 interactions | ERCC6 NEDD4L RGPD8 ATRX DDX60 TNIP2 PKP4 MINK1 LAMA1 DOCK10 FTSJ1 MYO1B RENBP NEB PRPF8 CWC22 IQGAP1 CRY2 UBE2D3 SUPT16H FGF2 FBXO39 VPS53 DYNC1H1 | 2.17e-05 | 1313 | 145 | 24 | int:USP7 |
| Interaction | EIF3K interactions | 3.39e-05 | 171 | 145 | 8 | int:EIF3K | |
| Interaction | MYLIP interactions | 5.12e-05 | 56 | 145 | 5 | int:MYLIP | |
| Interaction | CHFR interactions | 7.15e-05 | 60 | 145 | 5 | int:CHFR | |
| Interaction | RNF111 interactions | 7.22e-05 | 97 | 145 | 6 | int:RNF111 | |
| Interaction | ARK2C interactions | 7.65e-05 | 12 | 145 | 3 | int:ARK2C | |
| Interaction | RMC1 interactions | 1.17e-04 | 152 | 145 | 7 | int:RMC1 | |
| Interaction | UBXN6 interactions | 1.25e-04 | 325 | 145 | 10 | int:UBXN6 | |
| Interaction | ZNRF1 interactions | 1.27e-04 | 36 | 145 | 4 | int:ZNRF1 | |
| Interaction | UVSSA interactions | 1.41e-04 | 37 | 145 | 4 | int:UVSSA | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.73e-08 | 115 | 102 | 9 | 769 | |
| GeneFamily | Fibronectin type III domain containing | 3.42e-06 | 160 | 102 | 8 | 555 | |
| GeneFamily | Myosins, class I | 8.63e-04 | 8 | 102 | 2 | 1097 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.11e-03 | 206 | 102 | 6 | 682 | |
| GeneFamily | Ubiquitin conjugating enzymes E2 | 1.59e-03 | 41 | 102 | 3 | 102 | |
| GeneFamily | Anaphase promoting complex |Tetratricopeptide repeat domain containing | 2.74e-03 | 14 | 102 | 2 | 402 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 4.94e-10 | 33 | 144 | 7 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 1.28e-07 | 43 | 144 | 6 | MM3857 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | CNTN4 GALC DCDC1 ACSS1 GRIA1 SLC35G2 MEMO1 CLU CD36 MKX LRP1 PLEKHH2 AGBL2 ARAP2 | 3.62e-06 | 574 | 144 | 14 | M39056 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | RGPD4 RGPD2 RANBP2 AKT3 RGPD8 RGPD1 UBE2D3 WDR75 PHF20L1 RGPD3 IFT80 RGPD5 | 1.28e-05 | 474 | 144 | 12 | M40991 |
| Coexpression | GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN | 1.44e-05 | 198 | 144 | 8 | M9346 | |
| Coexpression | GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_UP | 3.82e-05 | 166 | 144 | 7 | M6811 | |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 4.21e-05 | 230 | 144 | 8 | M11563 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_DN | DOCK4 SEC16B HNF1A DCDC1 PPP1R3B MAN1C1 ACSS1 NEB ARID5A AGBL2 VEGFA | 4.88e-05 | 459 | 144 | 11 | M38993 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_100 | 2.37e-06 | 33 | 140 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | DOCK4 CNTN4 LAMA1 ANO1 COL6A5 RUNX1T1 CWC22 CLU NRK LRP1 ROBO2 ALDH1B1 | 6.83e-06 | 372 | 140 | 12 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | LAMA1 DOCK10 RUNX1T1 CWC22 CLU NRK LRP1 GLIPR2 SORCS3 ROBO2 ALDH1B1 PLEKHH2 | 7.02e-06 | 373 | 140 | 12 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_100 | 1.48e-05 | 80 | 140 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | DOCK4 CNTN4 MYO9A LAMA1 ANO1 COL6A5 RUNX1T1 CWC22 CLU NRK ZSCAN18 LRP1 GLIPR2 ROBO2 ALDH1B1 PLEKHH2 VEGFA | 2.04e-05 | 797 | 140 | 17 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | AKT3 ERCC6 NEDD4L STXBP5L ACSS1 ANO1 NEB CWC22 SIRT4 CREBRF SLCO5A1 CLIC5 PTPRZ1 SUPT16H TSPAN13 SORCS3 PLK4 PHTF1 | 2.43e-05 | 893 | 140 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | DOCK4 CNTN4 ERCC6 LAMA1 DOCK10 RUNX1T1 CWC22 CREBRF CLU NRK ZSCAN18 LRP1 GLIPR2 ROBO2 ALDH1B1 PLEKHH2 VEGFA | 4.51e-05 | 849 | 140 | 17 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_200 | 4.62e-05 | 143 | 140 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | DOCK4 CNTN4 LAMA1 ANO1 COL6A5 CLU NRK ZSCAN18 LRP1 ROBO2 ALDH1B1 | 5.07e-05 | 385 | 140 | 11 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | DOCK4 CNTN4 MYO1A LAMA1 DOCK10 RUNX1T1 CWC22 CLU NRK LRP1 GLIPR2 SORCS3 ROBO2 ALDH1B1 PLEKHH2 VEGFA | 7.01e-05 | 793 | 140 | 16 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | DOCK4 CNTN4 MYO1A LAMA1 ANO1 COL6A5 RUNX1T1 CWC22 CLU NRK LRP1 ROBO2 SCPEP1 ALDH1B1 PLEKHH2 VEGFA | 7.44e-05 | 797 | 140 | 16 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | RANBP2 CRLF1 NEDD4L DIS3L STXBP5L PPP1R3B ACSS1 ANO1 CWC22 SIRT4 UBE2D2 CLIC5 RBM27 PTPRZ1 NRK FGF2 ARAP2 DOP1A | 8.40e-05 | 983 | 140 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | DOCK4 CNTN4 MYO9A DTL LAMA1 DOCK10 NRK LRP1 ROBO2 PLEKHH2 VEGFA | 1.05e-04 | 418 | 140 | 11 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_200 | 1.38e-04 | 40 | 140 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | LAMA1 RUNX1T1 CWC22 CLU NRK LRP1 SORCS3 ROBO2 ALDH1B1 PLEKHH2 | 1.45e-04 | 361 | 140 | 10 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.65e-04 | 298 | 140 | 9 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | CNTN4 MYO1A MYO9A LAMA1 DOCK10 RUNX1T1 TMEM260 CLU NRK LRP1 GLIPR2 ROBO2 ALDH1B1 PLEKHH2 VEGFA | 1.70e-04 | 768 | 140 | 15 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | MYO1A LAMA1 ANO1 RUNX1T1 CWC22 CLU NRK MKX LRP1 GLIPR2 SORCS3 ROBO2 ALDH1B1 PLEKHH2 VEGFA | 1.93e-04 | 777 | 140 | 15 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | MAN1C1 DDX60 DOCK10 ANO1 COL6A5 CREBRF CLU PTPRZ1 CD36 MKX LRP1 FGF2 PLEKHH2 ANGPTL7 ARAP2 | 1.96e-04 | 778 | 140 | 15 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.02e-04 | 241 | 140 | 8 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.20e-04 | 244 | 140 | 8 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 2.25e-04 | 130 | 140 | 6 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | CNTN4 CRLF1 STXBP5L PPP1R3B TNIP2 DNAH2 DOCK10 SIRT4 CREBRF SLCO5A1 FNDC1 CSF2RB NRK MKX FGF2 SORCS3 DOP1A | 2.34e-04 | 973 | 140 | 17 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3 | CNTN4 CRLF1 DNAH2 DOCK10 ABCB6 RUNX1T1 FNDC1 CSF2RB NRK FGF2 | 2.38e-04 | 384 | 140 | 10 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 2.52e-04 | 249 | 140 | 8 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | AKT3 ERCC6 NEDD4L ATRX STXBP5L ACSS1 ANO1 ABCB6 CWC22 SLCO5A1 FNDC1 CLIC5 SUPT16H TSPAN13 PLK4 GOT1 PHTF1 | 2.73e-04 | 986 | 140 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500 | CNTN4 CRLF1 PPP1R3B DNAH2 DOCK10 ANO1 GRIA1 FNDC1 CSF2RB NRK FGF2 | 3.41e-04 | 479 | 140 | 11 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RANBP2 NEDD4L ATRX MYO9A STXBP5L UNC50 CLIC5 PTPRZ1 SUPT16H TSPAN13 ROBO2 SCPEP1 IFT80 ANAPC5 VPS53 | 3.95e-04 | 831 | 140 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_200 | 4.43e-04 | 54 | 140 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 5.01e-04 | 276 | 140 | 8 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_200 | 5.20e-04 | 152 | 140 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_200 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-08 | 160 | 146 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-08 | 160 | 146 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-07 | 190 | 146 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-07 | 192 | 146 | 8 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.30e-07 | 200 | 146 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 1.77e-06 | 174 | 146 | 7 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.06e-06 | 178 | 146 | 7 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.56e-06 | 184 | 146 | 7 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 2.56e-06 | 184 | 146 | 7 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.56e-06 | 184 | 146 | 7 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 2.85e-06 | 187 | 146 | 7 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-06 | 189 | 146 | 7 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.40e-06 | 192 | 146 | 7 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.40e-06 | 192 | 146 | 7 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.40e-06 | 192 | 146 | 7 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.64e-06 | 194 | 146 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.64e-06 | 194 | 146 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.76e-06 | 195 | 146 | 7 | 43164511f32e4591cb5399182fbac0b911716233 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.76e-06 | 195 | 146 | 7 | 9337111d75a487abc02969337718c30b1fe81379 | |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.16e-06 | 198 | 146 | 7 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.30e-06 | 199 | 146 | 7 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.30e-06 | 199 | 146 | 7 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.30e-06 | 199 | 146 | 7 | cd93e8947bcf3c2d7e6d5bfd70300145fba15f74 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_intermediate|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.30e-06 | 199 | 146 | 7 | debdd7dba774d9ccff7effc3f4c132393d203dfa | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.30e-06 | 199 | 146 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 4.30e-06 | 199 | 146 | 7 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | mLN-(5)_Dendritic_cell-(54)_pDC|mLN / shred on region, Cell_type, and subtype | 4.30e-06 | 199 | 146 | 7 | 1e738219784a446ee8b0ddeb408e0050e1929e60 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 4.30e-06 | 199 | 146 | 7 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | mLN-Dendritic_cell-pDC|mLN / Region, Cell class and subclass | 4.30e-06 | 199 | 146 | 7 | 54f1abb57af7bf8a8b82a38b933f257df3b5d8df | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.30e-06 | 199 | 146 | 7 | 212e89d097753790061310373a1fafba773488b6 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.30e-06 | 199 | 146 | 7 | 14b676aa289c0578a37be32cec3ea285c79d97cc | |
| ToppCell | (54)_pDC|World / shred on Cell_type and subtype | 4.90e-06 | 203 | 146 | 7 | b8ba3e51770ff7b45cd02472f3e63aa4d5816f6f | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 157 | 146 | 6 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 1.76e-05 | 165 | 146 | 6 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 2.30e-05 | 173 | 146 | 6 | 42c911ed16fabdabef063830e8407192d8bde950 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-05 | 174 | 146 | 6 | 9f2e253694eb5860c00528fda31c305c6de8a2a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-05 | 177 | 146 | 6 | 84116796ca4c7007508c0f1a68a1135c7b922278 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-05 | 179 | 146 | 6 | 7c8a2fa1326c73dc9e774df645b572864fd97133 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-aDC_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.97e-05 | 181 | 146 | 6 | 8f7e5c310f4cdc4b2fb54fea950d01e56bd298e1 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.25e-05 | 184 | 146 | 6 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.25e-05 | 184 | 146 | 6 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.35e-05 | 185 | 146 | 6 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 3.35e-05 | 185 | 146 | 6 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 3.46e-05 | 186 | 146 | 6 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | E17.5-Epithelial-alveolar_epithelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.46e-05 | 186 | 146 | 6 | a7a2ef8392a045a62fa4d0983577711d5d397dc4 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 186 | 146 | 6 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-05 | 187 | 146 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.56e-05 | 187 | 146 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.56e-05 | 187 | 146 | 6 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.67e-05 | 188 | 146 | 6 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 3.67e-05 | 188 | 146 | 6 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 189 | 146 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.78e-05 | 189 | 146 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 3.78e-05 | 189 | 146 | 6 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.89e-05 | 190 | 146 | 6 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.01e-05 | 191 | 146 | 6 | c383ae386bc53e73a683a9543c7dfed2a65257c5 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.01e-05 | 191 | 146 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.01e-05 | 191 | 146 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.13e-05 | 192 | 146 | 6 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.13e-05 | 192 | 146 | 6 | 39804d9ddc67c1b41887752df2503389eae44a1a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.13e-05 | 192 | 146 | 6 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.13e-05 | 192 | 146 | 6 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.13e-05 | 192 | 146 | 6 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.13e-05 | 192 | 146 | 6 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.13e-05 | 192 | 146 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.25e-05 | 193 | 146 | 6 | 54506c0da2f219f472b95e8935a78b657a8dec41 | |
| ToppCell | URO|World / Disease, Lineage and Cell Type | 4.25e-05 | 193 | 146 | 6 | 421dc0996c6c973f88e90197b651255ae4dd13a2 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.25e-05 | 193 | 146 | 6 | 33c495a2a7252b48ce10321642fd675d03cc80fc | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.25e-05 | 193 | 146 | 6 | 8e750a2b198ad6840a6842a7ddd93623faf7c656 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.25e-05 | 193 | 146 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.25e-05 | 193 | 146 | 6 | 6cc09f20dd119236c3c9968f3d16c3eabc0811e2 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.25e-05 | 193 | 146 | 6 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.25e-05 | 193 | 146 | 6 | 2d42721fac1bee294ede47d609bebb3e7d36bf0c | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.25e-05 | 193 | 146 | 6 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.37e-05 | 194 | 146 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.37e-05 | 194 | 146 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.37e-05 | 194 | 146 | 6 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.37e-05 | 194 | 146 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | PND01-Epithelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.37e-05 | 194 | 146 | 6 | d21db5e942966ed44bc78ff50130a201fc627074 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.37e-05 | 194 | 146 | 6 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.50e-05 | 195 | 146 | 6 | d673f8844896d5c7b76a7bc7f6b88a039f1bc263 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.63e-05 | 196 | 146 | 6 | 1756254a61ea92601ed5e223ef4471f010c12216 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 4.63e-05 | 196 | 146 | 6 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.63e-05 | 196 | 146 | 6 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 4.63e-05 | 196 | 146 | 6 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.63e-05 | 196 | 146 | 6 | eb68f7954e7c2f86d05e740e95b6e74805a6053f | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.63e-05 | 196 | 146 | 6 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.63e-05 | 196 | 146 | 6 | caa3c9555e1c656e88246ed31388a818f77610a1 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.76e-05 | 197 | 146 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.76e-05 | 197 | 146 | 6 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | 15-Distal-Epithelial-Bud_tip_progenitor|Distal / Age, Tissue, Lineage and Cell class | 4.76e-05 | 197 | 146 | 6 | 532635810f17199fa6c14b986f663884d5d05ab5 | |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.76e-05 | 197 | 146 | 6 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-G|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.76e-05 | 197 | 146 | 6 | a21a710c824f9e5c7ef1674168d1ce5aef85bd35 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.90e-05 | 198 | 146 | 6 | cf0fda1a24449cfd8ed56ffc7841d8accb187949 | |
| ToppCell | (5)_Dendritic_cell-(54)_pDC|(5)_Dendritic_cell / shred on Cell_type and subtype | 4.90e-05 | 198 | 146 | 6 | fc6c6b60dddd7f2f997af0f87fae33f1c23f34a8 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.90e-05 | 198 | 146 | 6 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.90e-05 | 198 | 146 | 6 | 7e1f08dae11a7cc7949a5622d82c7e6660d06dea | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.90e-05 | 198 | 146 | 6 | 525adc91fd8f2ad957b1879a5bf3950baa7d5ef8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.90e-05 | 198 | 146 | 6 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.90e-05 | 198 | 146 | 6 | 70e62d815b2a0aa5327ff94d6f4d503176e007b9 | |
| Disease | macular retinal edema (is_marker_for) | 2.23e-05 | 12 | 140 | 3 | DOID:4449 (is_marker_for) | |
| Disease | Corneal Neovascularization | 2.24e-05 | 2 | 140 | 2 | C0085109 | |
| Disease | Arthrogryposis | 1.31e-04 | 21 | 140 | 3 | C0003886 | |
| Disease | Thoracic Diseases | 1.33e-04 | 4 | 140 | 2 | C0039978 | |
| Disease | decubitus ulcer (biomarker_via_orthology) | 1.33e-04 | 4 | 140 | 2 | DOID:8717 (biomarker_via_orthology) | |
| Disease | thyroxine-binding globulin measurement | 2.21e-04 | 5 | 140 | 2 | EFO_0009172 | |
| Disease | polyarteritis nodosa (is_marker_for) | 2.21e-04 | 5 | 140 | 2 | DOID:9810 (is_marker_for) | |
| Disease | pre-eclampsia (is_implicated_in) | 2.23e-04 | 25 | 140 | 3 | DOID:10591 (is_implicated_in) | |
| Disease | Pathologic Neovascularization | 3.31e-04 | 6 | 140 | 2 | C0027686 | |
| Disease | Severe Congenital Microcephaly | 4.26e-04 | 31 | 140 | 3 | C3853041 | |
| Disease | response to 5-fluorouracil, response to antineoplastic agent | 4.62e-04 | 7 | 140 | 2 | GO_0036275, GO_0097327 | |
| Disease | Microlissencephaly | 5.14e-04 | 33 | 140 | 3 | C1956147 | |
| Disease | melanoma (is_marker_for) | 5.14e-04 | 33 | 140 | 3 | DOID:1909 (is_marker_for) | |
| Disease | retinal vein occlusion (biomarker_via_orthology) | 6.14e-04 | 8 | 140 | 2 | DOID:1727 (biomarker_via_orthology) | |
| Disease | Growth Disorders | 6.66e-04 | 36 | 140 | 3 | C0018273 | |
| Disease | pterygium (is_marker_for) | 7.87e-04 | 9 | 140 | 2 | DOID:0002116 (is_marker_for) | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 1.02e-03 | 93 | 140 | 4 | DOID:3525 (biomarker_via_orthology) | |
| Disease | acute insulin response measurement | 1.20e-03 | 11 | 140 | 2 | EFO_0006831 | |
| Disease | Gastric Adenocarcinoma | 1.28e-03 | 45 | 140 | 3 | C0278701 | |
| Disease | susceptibility to childhood ear infection measurement | 1.37e-03 | 171 | 140 | 5 | EFO_0007904 | |
| Disease | serum gamma-glutamyl transferase measurement | SEC16B HNF1A NEDD4L ATRX MYO9A MYO1B BHMT EPHA2 IFT80 ANAPC5 ARAP2 VEGFA | 1.41e-03 | 914 | 140 | 12 | EFO_0004532 |
| Disease | Weight Gain | 1.44e-03 | 102 | 140 | 4 | C0043094 | |
| Disease | Retinitis Pigmentosa | 1.55e-03 | 104 | 140 | 4 | C0035334 | |
| Disease | schizophrenia, anorexia nervosa | 1.55e-03 | 48 | 140 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | AKT3 NRAP DCDC1 MINK1 DOCK10 ELP1 RUNX1T1 PHF20L1 SORCS3 ROBO2 ARAP2 | 1.57e-03 | 801 | 140 | 11 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | alcohol and nicotine codependence | 1.68e-03 | 13 | 140 | 2 | EFO_0004776 | |
| Disease | diabetic retinopathy (is_implicated_in) | 1.74e-03 | 50 | 140 | 3 | DOID:8947 (is_implicated_in) | |
| Disease | Influenza | 1.95e-03 | 52 | 140 | 3 | C0021400 | |
| Disease | Malformations of Cortical Development | 1.96e-03 | 14 | 140 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 1.96e-03 | 14 | 140 | 2 | C0431380 | |
| Disease | diabetic neuropathy (is_implicated_in) | 1.96e-03 | 14 | 140 | 2 | DOID:9743 (is_implicated_in) | |
| Disease | Hermansky-Pudlak syndrome (implicated_via_orthology) | 1.96e-03 | 14 | 140 | 2 | DOID:3753 (implicated_via_orthology) | |
| Disease | Glioblastoma Multiforme | 1.96e-03 | 111 | 140 | 4 | C1621958 | |
| Disease | basophil count | 2.21e-03 | 483 | 140 | 8 | EFO_0005090 | |
| Disease | glucose measurement | 2.31e-03 | 380 | 140 | 7 | EFO_0004468 | |
| Disease | cholesteatoma of middle ear (is_marker_for) | 2.57e-03 | 16 | 140 | 2 | DOID:10964 (is_marker_for) | |
| Disease | white matter microstructure measurement | 2.67e-03 | 390 | 140 | 7 | EFO_0005674 | |
| Disease | cyclic adenosine monophosphate measurement | 2.90e-03 | 17 | 140 | 2 | EFO_0010473 | |
| Disease | non-Hodgkin lymphoma (is_implicated_in) | 2.90e-03 | 17 | 140 | 2 | DOID:0060060 (is_implicated_in) | |
| Disease | Liver Cirrhosis, Experimental | GALC PPP1R3B DOCK10 IQGAP1 CD36 FGF2 ROBO2 ALDH1B1 GOT1 VEGFA | 3.93e-03 | 774 | 140 | 10 | C0023893 |
| Disease | Microcephaly | 4.01e-03 | 67 | 140 | 3 | C0025958 | |
| Disease | coronary artery disease (is_marker_for) | 4.01e-03 | 67 | 140 | 3 | DOID:3393 (is_marker_for) | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 4.02e-03 | 20 | 140 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | Abdominal Aortic Aneurysm | 4.18e-03 | 68 | 140 | 3 | EFO_0004214 | |
| Disease | Antimigraine preparation use measurement | 4.42e-03 | 21 | 140 | 2 | EFO_0009939 | |
| Disease | Lymphoma, Diffuse | 4.42e-03 | 21 | 140 | 2 | C3714542 | |
| Disease | Low Grade Lymphoma (neoplasm) | 4.42e-03 | 21 | 140 | 2 | C0079747 | |
| Disease | Lymphoma, Intermediate-Grade | 4.42e-03 | 21 | 140 | 2 | C0079741 | |
| Disease | High Grade Lymphoma (neoplasm) | 4.42e-03 | 21 | 140 | 2 | C0079740 | |
| Disease | Diffuse Mixed-Cell Lymphoma | 4.42e-03 | 21 | 140 | 2 | C0079757 | |
| Disease | Lymphoma, Undifferentiated | 4.42e-03 | 21 | 140 | 2 | C0024306 | |
| Disease | Reticulosarcoma | 4.42e-03 | 21 | 140 | 2 | C0024302 | |
| Disease | Lymphoma, Mixed-Cell | 4.42e-03 | 21 | 140 | 2 | C0024304 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LWQYRDLRSIYKKDG | 991 | Q99569 | |
| ATRWDIQKYAREAYN | 276 | Q93088 | |
| TSKVRRWENYYLGKF | 236 | B9A014 | |
| INEKGSDRYRNAYVW | 81 | Q14507 | |
| KREVQLRLSYVYDWS | 301 | Q96L58 | |
| KYGDAWVKKYDRSSL | 396 | Q9NUB1 | |
| AYELVTGRRLWKNVY | 101 | Q03989 | |
| AIEVNKRDYRAWYGL | 391 | Q9UJX2 | |
| FERVDYVKGKLWYNE | 286 | Q9H7T0 | |
| RKRGKRRYFWEYSEQ | 426 | Q8IUR6 | |
| EVIKVYRYFAGWADK | 141 | P30837 | |
| YWAITNAIEYARKRT | 121 | P28566 | |
| SEVKGYKVLYRWNRQ | 931 | Q8IWV2 | |
| YREAIIKYQGLEWKS | 476 | Q9NP58 | |
| YKKRLEDQGVRVTWY | 356 | Q5VUY2 | |
| SLSGYQYTRRAWKKE | 2096 | Q5JWR5 | |
| QKRWVKFDGLSISYY | 501 | Q8WZ64 | |
| WITRKEYEEKGGEYL | 551 | Q9H9F9 | |
| KVWDLRKNYTAYRQE | 241 | Q9NZJ0 | |
| TGLWRYLKNAYARDE | 371 | Q9NZA1 | |
| GDEDYYKQRLRRWNK | 456 | Q03468 | |
| GEYIKNWRPRYFLLK | 16 | Q9Y243 | |
| WRGYKQKKAYQDRLA | 786 | P46940 | |
| RAKLYRYDKDVGQWK | 2336 | P49792 | |
| YREKYDWRRGRSKSR | 156 | Q9P2N5 | |
| RVWRDGQKKTCYIYR | 606 | Q92698 | |
| AEIYRYDKDVGQWKE | 1361 | Q99666 | |
| AEIYRYDKDVGQWKE | 1361 | O14715 | |
| RRKSGLVSFYRDWKQ | 176 | O43827 | |
| WLYVLGQKRSDSYVL | 346 | Q9UJX4 | |
| GRVYDDLKYVWLQGR | 56 | P51606 | |
| NEQKIWVSYGRAYRS | 571 | M0R2J8 | |
| NAELERKIKGWYEKY | 111 | Q7Z3Y7 | |
| IALDYKREAKGELYW | 791 | Q2M2H8 | |
| RYKESWRNLRAQGYK | 1271 | Q86VF7 | |
| YWIRRYSDAEDLKKG | 391 | Q06455 | |
| GWKARKNYRKYFRSE | 756 | Q9UBC5 | |
| FLYRREKAAGEKVYW | 436 | Q4VC44 | |
| LYWTDVVEDKIYRGK | 1311 | Q07954 | |
| YQNGAERRWEKSSRY | 871 | Q9HCG8 | |
| KDYEYLWNTVSKLVR | 406 | Q8IY21 | |
| DLSWALRIKLYNKYV | 136 | Q8IYA7 | |
| ESAVWYVKKFGRYLE | 76 | Q8N4B4 | |
| QEYRLYREKKSASWI | 56 | Q8N423 | |
| TQKRAALYTWYVRKQ | 156 | P20823 | |
| GAAWEEALRLVYKYN | 1086 | O95163 | |
| NDRKLLYEEWARYGV | 296 | Q5XXA6 | |
| YRQQRKLVEEIGWSY | 26 | P23471 | |
| KRRWFVLKGGELLYY | 721 | Q8IVE3 | |
| LKKLLERIGYSNEWY | 301 | Q8N127 | |
| RAEFYRYDKDVGQWK | 1361 | A6NKT7 | |
| YKGEGKWLRNIDYYR | 2071 | P46100 | |
| KWLRNIDYYRLDGST | 2076 | P46100 | |
| YGYRLRRKWEEKIPN | 466 | P32927 | |
| YNWERALELAVKYKT | 696 | Q9P2H3 | |
| VLRYAAKFYRRKNSW | 251 | Q13325 | |
| VGVYDKTSRYWRIKS | 226 | Q9BXC9 | |
| EWLRIGNKYITLKDY | 81 | A6NFR6 | |
| IAALIAEYLKRKGYW | 1726 | Q96BY6 | |
| GALAYRDLIKVLKWY | 671 | Q8N1I0 | |
| KTEYLVRWKGYDSED | 76 | Q9Y232 | |
| YRLWDLYKKVKRNST | 286 | Q49AN0 | |
| GKEVADRWYSEIKNY | 76 | Q9H4G4 | |
| IIDTYKGKRNLSYWE | 226 | P16671 | |
| QYTVRYREKGELARW | 296 | Q4ZHG4 | |
| YREKGELARWDYKQI | 301 | Q4ZHG4 | |
| DKASYEIKKVWYGRT | 566 | Q8TF46 | |
| VWKYEVTYRKKGDSN | 466 | P29317 | |
| RRLYLNEKGWNKYTK | 421 | Q5T1B0 | |
| SYLIRWSDYNRKKQL | 1811 | A8TX70 | |
| KVADWTGATYQDKRY | 41 | O15371 | |
| NEIASVAYRYRRWKL | 351 | O15371 | |
| VAYRYRRWKLGDDID | 356 | O15371 | |
| DYWVVGKKSDRRELY | 436 | P86791 | |
| FSLKYWIRYKRQGAA | 161 | Q14213 | |
| DYWVVGKKSDRRELY | 436 | P86790 | |
| IRSYRYWDAEKRGLD | 156 | P17174 | |
| IGWRREGNEIKYYKN | 351 | Q5U5Z8 | |
| GKVEQKLRWYFKLYD | 86 | P43080 | |
| DNRIGGKYWKVRYTE | 421 | Q6MZM0 | |
| WQSYKRYAMGKNELR | 186 | Q9NR34 | |
| GDWKSYQYLVESIRR | 276 | Q5HYK3 | |
| QERLRYAPLGWSKKY | 4191 | Q14204 | |
| RKYTSWYVALKRTGQ | 251 | P09038 | |
| KWQKFVYIYDADRGL | 141 | P42261 | |
| KYQIRYRVEDSVDWK | 271 | O75462 | |
| IYALGRVEVTAKKWY | 616 | P54803 | |
| IDYGFWYDRTKQTIK | 2506 | Q9P225 | |
| WTYGRYIRSALRQEK | 696 | O60716 | |
| YWDSNRGKNYRIIRA | 221 | Q86XI6 | |
| AELYRYDKDVGQWKE | 1346 | P0DJD0 | |
| LIIQNWYRGYKARLK | 21 | O14829 | |
| AKYRYDKEWLNNGRM | 736 | A8MW92 | |
| DKYRASIRGKKWYSS | 471 | Q8N328 | |
| YDLRIDQKIYGELWK | 101 | Q9Y316 | |
| SGKRNKLRVYYLSWL | 1076 | Q8N4C8 | |
| RVNKYQKSVGWRYSD | 71 | Q7Z2Y5 | |
| LDWAYRSGGYKKARA | 481 | Q9NYH9 | |
| RAELYRYDKDVGQWK | 1361 | Q7Z3J3 | |
| FWKATRSYLQYRGKK | 981 | A5PLK6 | |
| KWKENGYYRAIVTKL | 546 | O60522 | |
| KMYSREWNRDVQYRG | 66 | P09132 | |
| SREKTSDIYIKGWLY | 1741 | A0AVI2 | |
| LYRYDKDVGQWKERG | 1356 | P0DJD1 | |
| QVKTYITYNKGRDWR | 511 | Q9UPU3 | |
| GKEVWDYVTVRKDAY | 36 | Q9HB40 | |
| FVLAGYKLYWRNLRK | 386 | Q8TBE7 | |
| IRKEYWRYIGRSLQS | 351 | P49354 | |
| LLTDRRYNNGTWYKI | 2376 | P25391 | |
| AWYSIKYKEDGLQRR | 756 | Q9H2Y9 | |
| IWREQYEKAYLKSLD | 591 | O75182 | |
| YSGYRFILTAWEKKL | 266 | Q9Y6E7 | |
| RYKAGTEKLRWNAFE | 231 | Q9NY99 | |
| SRYSFDNLPEKYWRK | 671 | O00444 | |
| YRRVKRLYSNWRKGE | 11 | Q9Y5B9 | |
| ERGSRKWNYIYDKLS | 251 | Q96PQ1 | |
| WDLKSKRAELRVYYD | 236 | Q9Y2K9 | |
| WYTKYASRLAGKENI | 121 | Q5VW32 | |
| IKRRLENNYYWAASE | 126 | P25440 | |
| GSYIYQKRWVRLDTD | 341 | Q96P48 | |
| RLTRKYNELLKSYQW | 336 | P10909 | |
| GVQRKRADKYWEYTF | 361 | Q9C0B9 | |
| AYDKGWRVRTDFKQY | 1431 | Q6P2Q9 | |
| ENKKEYVRLYVNWRF | 576 | Q9HAU4 | |
| KWQRYNASRDEYVRG | 226 | Q8NFZ5 | |
| SLKSRGYVKEQFAWR | 51 | P46783 | |
| REKYNRIAREWTQKY | 131 | P62837 | |
| LVKRQSRDYDVEWGY | 141 | Q53HI1 | |
| KRFSYNRYWRDKLDT | 826 | Q13107 | |
| ILGVWLTYRYRNQKD | 181 | O95857 | |
| KARQWKYDGEMLNRY | 641 | Q99973 | |
| RDAISWYQKKIGAYD | 6 | Q9UMS5 | |
| KIRLWRNFYDDKKYT | 226 | Q8IWA0 | |
| GNKAYRTWYAKLDEE | 136 | Q15257 | |
| RDKYNRISREWTQKY | 131 | P61077 | |
| WYKRGVKENSIITKY | 101 | O95391 | |
| YWRRKKRKGLSNYAV | 881 | Q9HCK4 | |
| IKAGDALWLRFKYYS | 241 | Q86UX7 | |
| FDLDLAWRLLKNYYK | 61 | P49638 | |
| FQKYLREYAWKILSG | 501 | Q5VIR6 | |
| TRLLYYGRKKEALEW | 446 | Q96JE7 | |
| VYYRLAKENGWRARS | 11 | Q9UET6 | |
| EENLKSYRKLLLWGY | 236 | Q8TBC5 | |
| REKYNRLAREWTQKY | 131 | Q9Y2X8 | |
| KKSRYKSWSVYVGAR | 156 | P15692 | |
| KLTKSIYNWTEEYGR | 561 | Q9NX78 | |
| QEKIIRGYEAKWIYI | 246 | A6PVS8 | |
| AYWLGLKVRREYRKF | 846 | O43795 | |
| CIQARWKAYRESKRY | 1121 | B2RTY4 | |
| WKAYRESKRYQEQRK | 1126 | B2RTY4 | |
| YKRDWYDLIAKGNNV | 1296 | P20929 | |
| ARILDQYLYKEGWER | 4206 | P20929 | |
| WEERKDAKGRTYYVN | 391 | Q96PU5 |